NOD mice and autoimmunity

Autoimmunity Reviews

Volumn 4, Issue 6, 2005, Pages 373-379

  Aoki, Christopher A ^a   Borchers, Andrea T ^a   Ridgway, William M ^b   Keen, Carl L ^c   Ansari, Aftab A ^d   Gershwin, M Eric ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Apoptosis; T cell signaling; Thymic education; Tolerance

Indexed keywords

CD40 LIGAND MONOCLONAL ANTIBODY; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ACCESSORY CELL; APOPTOSIS; AUTOIMMUNE DISEASE; AUTOIMMUNITY; CELL STIMULATION; DIABETES MELLITUS; DISEASE PREDISPOSITION; GENE LOCUS; GENETIC MANIPULATION; GENETIC SUSCEPTIBILITY; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MOUSE; NONHUMAN; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE;

ANIMALS; AUTOIMMUNE DISEASES; DIABETES MELLITUS, TYPE 1; GENETIC PREDISPOSITION TO DISEASE; MICE; MICE, INBRED NOD;

EID: 23144438406     PISSN: 15689972     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.autrev.2005.02.002     Document Type: Review

References (40)

1. + T cells controlling distinct organ-specific autoimmune diseases Proc Natl Acad Sci U S A 100 2003 Dec. 23 15806 15811 Epub 2003 Dec. 12. Erratum in: Proc Natl Acad Sci U S A. 2004 Mar. 23;101(12):4331
2. R. Tisch, and H. McDevitt Insulin-dependent diabetes mellitus Cell 85 1996 291 297
3. E. Carrasco-Marin, J. Shimizu, O. Kanagawa, and E.R. Unanue The class II MHC I-Ag7 molecules from non-obese diabetic mice are poor peptide binders Immunology 156 2 1996 (Jan. 15) 450 458
4. g7 molecule: rapid release of CLIP at an endosomal pH J Exp Med 189 1999 1723 1734
5. T. Stratmann, V. Apostolopoulos, V. Mallet-Designe, A.L. Corper, C.A. Scott, and I.A. Wilson The I-Ag7 MHC class II molecule linked to murine diabetes is a promiscuous peptide binder J Immunol 165 6 2000 (Sep. 15) 3214 3225
6. g7-dependent reaction Proc Natl Acad Sci U S A 95 1998 1721 1724
7. W.M. Ridgway, H. Ito, M. Fasso, C. Yu, and C.G. Fathman Analysis of the role of variation of major histocompatibility complex class II expression on nonobese diabetic (NOD) peripheral T cell response J Exp Med 188 12 1998 (Dec. 21) 2267 2275
8. L.S. Wicker, J.A. Todd, and L.B. Peterson Genetic control of autoimmune diabetes in the NOD mouse Annu Rev Immunol 13 1995 179 200
9. P.L. Podolin, M.B. Wilusz, R.M. Cubbon, U. Pajvani, C.J. Lord, and J.A. Todd Differential glycosylation of interleukin 2, the molecular basis for the NOD Idd3 type 1 diabetes gene? Cytokine 12 5 2000 May 477 482
10. N.J. Hill, P.A. Lyons, N. Armitage, J.A. Todd, L.S. Wicker, and L.B. Peterson NOD Idd5 locus controls insulitis and diabetes and overlaps the orthologous CTLA4/IDDM12 and NRAMP1 loci in humans Diabetes 49 2000 1744 1747
11. L. Vijayakrishnan, J.M. Slavik, Z. Illes, R.J. Greenwald, D. Rainbow, and B. Greve An autoimmune disease-associated CTLA-4 splice variant lacking the B7 binding domain signals negatively in T cells Immunity 20 5 2004 (May) 563 575
12. H. Ueda, J.M. Howson, L. Esposito, J. Heward, H. Snook, and G. Chamberlain Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease Nature 423 6939 2003 May 29 506 511 Epub 2003 Apr. 30
13. H. Kishimoto, and J. Sprent A defect in central tolerance in NOD mice Nat Immunol 2 2001 1025 1031
14. S. Lesage, S.B. Hartley, S. Akkaraju, J. Wilson, M. Townsend, and C.C. Goodnow Failure to censor forbidden clones of CD4 T cells in autoimmune diabetes J Exp Med 196 2002 1175 1188
15. A. Liston, S. Lesage, D.H. Gray, L.A. O'Reilly, A. Strasser, and A.M. Fahrer Generalized resistance to thymic deletion in the NOD mouse; a polygenic trait characterized by defective induction of Bim Immunity 21 2004 817
16. + T cell intrinsic and independent of APC genetic background J Immunol 169 2002 6580 6587
17. J. Heward, H. Snook, G. Chamberlain, D.B. Rainbow, K.M. Hunter, and A.N. Smith Interleukin 4 reverses T cell proliferative unresponsiveness and prevents the onset of diabetes in nonobese diabetic mice J Exp Med 178 1 1993 July 1 87 99
18. G.A. Arreaza, M.J. Cameron, A. Jaramillo, B.M. Gill, D. Hardy, and K.B. Laupland Neonatal activation of CD28 signaling overcomes T cell anergy and prevents autoimmune diabetes by an IL-4-dependent mechanism J Clin Invest 100 9 1997 Nov. 1 2243 2253
19. + T cells is associated with defective peripheral tolerance in nonobese diabetic mice Clin Immunol 107 2 2003 May 103 115
20. E. Dahlen, G. Hedlund, and K. Dawe Low CD86 expression in the nonobese diabetic mouse results in the impairment of both T cell activation and CTLA-4 up-regulation J Immunol 164 2000 2444
21. + immunoregulatory T cells that control autoimmune diabetes Immunity 12 4 2000 Apr. 431 440
22. H. Bour-Jordan, B.L. Salomon, H.L. Thompson, G.L. Szot, M.R. Bernhard, and J.A. Bluestone Costimulation controls diabetes by altering the balance of pathogenic and regulatory T cells J Clin Invest 114 2004 979
23. F. Colucci, M.L. Bergman, C. Penha-Gonçalves, C.M. Cilio, and D. Holmberg Apoptosis resistance of nonobese diabetic peripheral lymphocytes linked to the Idd5 diabetes susceptibility region Proc Natl Acad Sci U S A 94 1997 8670 8674
24. F. Lühder, P. Höglund, J.P. Allison, C. Benoist, and D. Mathis Cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) regulates the unfolding of autoimmune diabetes J Exp Med 187 1998 427 432
25. + T regulatory cells dependent on ICOS promote regulation of effector cells in the prediabetic lesion J Exp Med 199 2004 1479 1489
26. M.J. Ansari, A.D. Salama, T. Chitnis, R.N. Smith, H. Yagita, and H. Akiba The programmed death-1 (PD-1) pathway regulates autoimmune diabetes in nonobese diabetic (NOD) mice J Exp Med 198 1 2003 July 7 63 69
27. B. Balasa, T. Krahl, G. Patstone, J. Lee, R. Tisch, and H.O. McDevitt CD40 ligand-CD40 interactions are necessary for the initiation of insulitis and diabetes in nonobese diabetic mice J Immunol 159 1997 4620
28. + T cells dissociated from activation of antigen-presenting cells Immunity 16 5 2002 May 719 732
29. S. Trembleau, G. Penna, S. Gregori, N. Giarratana, and L. Adorini IL-12 administration accelerates autoimmune diabetes in both wild-type and IFN-γ-deficient nonobese diabetic mice, revealing pathogenic and protective effects of IL-12-induced IFN-γ J Immunol 170 2003 5491 5501
30. C. Chen, W.H. Lee, P. Yun, P. Snow, and C.P. Liu Induction of autoantigen-specific Th2 and Tr1 regulatory T cells and modulation of autoimmune diabetes J Immunol 171 2003 733 744
31. + T cell levels in NOD mice Proc Natl Acad Sci U S A 99 2002 12287 12292
32. F.D. Shi, M. Flodström, B. Balasa, S.H. Kim, K. Van Gunst, and J.L. Strominger Germ line deletion of the CD1 locus exacerbates diabetes in the NOD mouse Proc Natl Acad Sci U S A 98 12 2001 June 5 6777 6782
33. S. Sharif, G.A. Arreaza, P. Zucker, Q.S. Mi, J. Sondhi, and O.V. Naidenko Activation of natural killer T cells by alpha-galactosylceramide treatment prevents the onset and recurrence of autoimmune Type 1 diabetes Nat Med 7 2001 1057
34. A.G. Baxter, A.C. Horsfall, D. Healey, P. Ozegbe, S. Day, and D.G. Williams Mycobacteria precipitate an SLE-like syndrome in diabetes-prone NOD mice Immunology 83 1994 227
35. I. Krause, Y. Tomer, D. Elias, M. Blank, B. Gilburd, and I.R. Cohen Inhibition of diabetes in NOD mice by idiotypic induction of SLE J Autoimmun 13 1 1999 Aug. 49 55
36. H. Braley-Mullen, G.C. Sharp, B. Medling, and H. Tang Spontaneous autoimmune thyroiditis in NOD.H-2h4 mice J Autoimmun 12 1999 157 165
37. J.F. Elliott, J. Liu, Z.N. Yuan, N. Bautista-Lopez, S.L. Wallbank, and K. Suzuki Autoimmune cardiomyopathy and heart block develop spontaneously in HLA-DQ8 transgenic IAβ knockout NOD mice Proc Natl Acad Sci U S A 100 23 2003 Nov. 11 13447 13452 Epub 2003 Oct. 21
38. B. Salomon, L. Rhee, H. Bour-Jordan, H. Hsin, A. Montag, and B. Soliven Development of spontaneous autoimmune peripheral polyneuropathy in B7-2-deficient NOD mice J Exp Med 194 5 2001 Sep. 3 677 684 Erratum in J Exp Med 2001 Nov. 5;194(9):1393
39. D.V. Serreze, M.A. Pierce, C.M. Post, H.D. Chapman, H. Savage, and R.T. Bronson Paralytic autoimmune myositis develops in nonobese diabetic mice made Th1 cytokine-deficient by expression of an IFN-gamma receptor beta-chain transgene J Immunol 170 2003 2742
40. S. Koarada, Y. Wu, N. Fertig, D.A. Sass, M. Nalesnik, and J.A. Todd Genetic control of autoimmunity: protection from diabetes, but spontaneous autoimmune biliary disease in a nonobese diabetic congenic strain J Immunol 173 4 2004 Aug. 15 2315 2323